The Clinical Implications of Death Domain-Associated Protein (DAXX) Expression.
Conclusion: This investigation found upregulation of DAXX in esophageal cancer, with a 71.7% expression rate. DAXX immunostaining could be used in clinical practice to predict aggressive tumors with lymph node metastasis in advanced-stage disease, especially in stages IIB and IV.
PMID: 29854663 [PubMed]
Source: Korean Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Korean J Thorac Cardiovasc Surg Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Esophagus Cancer | Heart | Skin Cancer | Squamous Cell Carcinoma | Study